FEED insider trading
HealthcareENvue Medical, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ENvue Medical, Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. The company's product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also provides UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it offers PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. ENvue Medical, Inc. was incorporated in 2003 and is based in Tyler, Texas.
Company website: envuemed.com
FEED insider activity at a glance
FilingIQ has scored 32 insider transactions for FEED since Jan 14, 2026. The most recent filing in our index is dated Apr 15, 2026.
Across the full history, 1 open-market purchases
and 30 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on FEED insider trades is 45.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for FEED?
- FilingIQ tracks 32 Form 4 insider transactions for FEED (ENvue Medical, Inc.), covering filings from Jan 14, 2026 onwards. 1 of those were filed in the last 90 days.
- Are FEED insiders net buyers or net sellers?
- Across the full Form 4 history for FEED, 1 transactions (3%) were open-market purchases and 30 (94%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does FEED insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is FEED in?
- ENvue Medical, Inc. (FEED) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.86M.
Methodology & sources
Every FEED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.